tirzepatide rhabdomyolysis In a 28-year-old female who received a subcutaneous 5 mg injection and developed muscle pain in the neck, trapezius, triceps, back, waist and quadriceps the next day, what is the likely tirzepatide rhabdomyolysis Neuromuscular Notes: Rhabdomyolysis

Compounded vials require thinking in mL or insulin syringe units

The decision to stop tirzepatide should always involve shared decision-making with your healthcare provider, considering individual circumstances, treatment goals, and the availability of alternative management strategies

2022;387:205216 NCPA

As a stimulant, it can delay your dropping off to sleep, reduce the time you stay asleep and reduce the length of deep, slow-wave sleep

It is also important to rule out unrelated medical causes of fatigue, particularly if the tiredness feels disproportionate to the degree of appetite suppression or gastrointestinal symptoms experienced